Zota Health Care LImited

Web: zotahealthcare.com NSE: ZOTA SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1130 29(3%)

Near 52W Low of 1024

Volume

2L as on 23, Jun

Open

819

High

859

Low

810

1,101

VWAP

1,380

52 Week High

1,740

52 Week Low

1,024

Viand Research Rating

Quality Score

4/100

Growth Score

50/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

3,915

No. of Shares

3.46

P/E

P/B

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

19-Aug-19

Promoter Holding

49.38%

FII Holding

7.92%

DII Holding

6.75%

Price Chart

Price Performance

1 Week13%

1 Month15%

3 Months32%

6 Months17%

1 Year17%

YTD17%

Moving Average

5 Day SMA1,310

10 Day SMA1,265

20 Day SMA1,221

30 Day SMA1,213

50 Day SMA1,250

61 Day SMA1,227

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,485	1,393	1,431	1,526
Resistance 2	1,431	1,385	1,399	1,451
Resistance 1	1,400	1,377	1,379	1,440
Pivot Point	1,346	1,369	1,346	1,366
Support 1	1,315	1,362	1,314	1,356
Support 2	1,261	1,354	1,294	1,281
Support 3	1,230	1,346	1,261	1,270

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Apr 2025	Mar 2025	Feb 2025	Dec 2024	Sep 2024	Aug 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 49.38%	(-1.31) 49.38%	(-5.21) 50.64%	(-1.61) 55.81%	(-0.71) 57.42%	(-1.61) 58.11%	(0.01) 59.72%	(-2.31) 59.72%	(-0.41) 62.02%	(0.01) 62.40%	(-2.01) 62.40%	(-1.71) 64.44%	(0.01) 66.15%	(0.01) 66.15%	(-2.01) 66.16%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.12%	(0.01) 68.11%	(0.01) 68.09%
FIIs	(-0.31) 7.92%	(0.11) 8.21%	(4.61) 8.09%	(-0.31) 3.49%	(0.21) 3.82%	(2.71) 3.60%	(-0.21) 0.87%	(0.81) 1.02%	(0.21) 0.24%	(0.01) 0.01%	(0.01) 0.02%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.02%	(0.01) 0.04%	(0.01) 0.00%	(-0.11) 0.00%	(0.11) 0.07%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.41) 6.75%	(-0.81) 6.40%	(2.31) 7.22%	(0.71) 4.95%	(1.31) 4.25%	(-0.21) 2.92%	(0.01) 3.08%	(2.11) 3.08%	(0.01) 1.03%	(0.21) 0.99%	(0.81) 0.76%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(-0.41) 0.05%	(0.21) 0.45%	(0.01) 0.30%	(0.01) 0.34%
Public	35.96%	36.00%	34.06%	35.75%	34.52%	35.38%	36.33%	36.18%	36.71%	36.60%	36.82%	35.55%	33.85%	33.85%	33.83%	31.84%	31.88%	31.88%	31.75%	31.43%	31.59%	31.57%
No. of Shareholders	14,678	14,005	13,185	11,855	10,354	10,382	10,389	10,324	9,763	8,937	9,369	7,661	7,435	7,589	7,285	7,107	7,233	7,956	7,866	8,149	7,817	7,255

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	174	163	143	129	104	97	72	67	56	50	47	45	39	37	35	39	29	31	31	35	33
Sales Growth % (YoY)	68%	68%	98%	92%	84%	96%	54%	49%	46%	35%	34%	16%	32%	18%	13%	10%	-13%	2%	2%	25.6%	90.5%
Sales Growth % (QoQ)	6.7%	14%	10.9%	24%	7.2%	34.7%	7.5%	19.6%	12%	6.4%	4.4%	15.4%	5.4%	5.7%	-10.3%	34.5%	-6.5%	-	-11.4%	6.1%	-
Expenses	185	154	143	123	100	95	78	68	58	51	44	41	37	36	35	34	28	31	26	31	29
Operating Profit	-12	9	0	6	4	2	-6	-1	-1	-1	3	4	1	1	0	5	1	0	5	5	5
OPM %	-7	5	-0.3	4.9	3.8	2.5	-8	-1.3	-2.2	-3	7	10	3.3	3	0	12	5	0	16	14	15
Other Income	2	-3	2	2	1	1	1	1	0	0	0	0	0	1	1	1	0	1	0	0	0
Interest	6	5	5	4	3	3	2	3	3	2	1	1	1	1	1	1	0	0	0	0	0
Depreciation	28	27	22	19	15	14	11	10	8	7	5	5	3	4	3	3	2	2	1	1	1
Profit before tax	-44	-26	-26	-14	-13	-14	-18	-13	-12	-10	-3	-1	-3	-3	-3	2	0	-1	5	4	5
Tax %	1	-45	14	13	5	-10	2	-4	5	-27	7	49	1	-15	-4	58	119	1	26	26	26
Net Profit	-44	-14	-30	-16	-14	-13	-19	-12	-13	-7	-3	-2	-3	-3	-3	1	-1	-1	3	3	3
Net Profit Growth % (QoQ)	-214.3%	53.3%	-87.5%	-14.3%	-7.7%	31.6%	-58.3%	7.7%	-85.7%	-133.3%	-50%	33.3%	-	-	-400%	200%	-	-133.3%	-	-	-
Net Profit Growth % (YoY)	-214.3%	-7.7%	-57.9%	-33.3%	-7.7%	-85.7%	-533.3%	-500%	-333.3%	-133.3%	-	-300%	-200%	-200%	-200%	-66.7%	-133.3%	-	-	-	-
TTM Net Profit	-104	-74	-73	-62	-58	-57	-51	-35	-25	-15	-11	-11	-8	-6	-4	2	4	8	9	6	0
EPS in Rs	-12.58	-4.09	-8.73	-5.2	-4.81	-4.5	-6.78	-4.41	-4.79	-2.68	-1.14	-0.64	-1.13	-1.05	-1.28	0.36	-0.33	-0.4	1.33	1.28	1.37

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2015	Mar 2014	Mar 2012	Mar 2011
Sales	539	292	180	139	131	106	95	85	56	50	38	25
Sales Growth %	85%	62%	29%	7%	23%	12%	11%	-	13%	-	52%	-
Expenses	520	298	173	132	116	105	90	77	47	43	33	21
Operating Profit	19	-6	8	7	15	1	5	8	8	6	5	4
OPM %	3.4	-2	4.2	5	11	0.6	4.8	9	15	13	13	14
Other Income	1	2	1	2	2	2	2	2	0	0	0	0
Interest	17	11	5	3	0	0	0	0	1	1	1	0
Depreciation	82	43	20	12	4	3	2	1	2	1	1	0
Profit before tax	-80	-58	-16	-5	12	0	4	8	6	5	3	3
Tax %	-7	-2	-11	23	28	-41	29	29	33	33	33	34
Net Profit	-74	-57	-14	-6	9	0	3	6	4	3	2	2
Net Profit Growth %	-29.8%	-307.1%	-133.3%	-166.7%	-	-100%	-50%	50%	33.3%	50%	-	-
EPS in Rs	-21.35	-19.7	-5.55	-2.29	3.54	-0.09	1.12	2.26	2.12	1.85	1.43	2.17
Dividend Payout %	-5	-5	-18	-44	42	-1170	90	32	34	38	50	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2015	Mar 2014
Cash from Operating Activity	-84	-50	-6	-2	13	-1	6	-3	5	3
Cash from Investing Activity	-314	-92	-13	15	-27	4	-4	9	-1	-1
Cash from Financing Activity	490	145	19	-14	14	-2	-3	-6	-4	-2
Net Cash Flow	92	3	0	-1	1	1	-1	-1	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2015	Mar 2014	Mar 2012	Mar 2011
Equity Capital	35	31	29	27	26	25	25	25	25	18	14	12	10	7
Reserves	659	285	195	132	64	55	64	42	44	51	4	4	3	5
Borrowings	270	181	140	107	95	45	15	0	0	0	5	5	6	3
Other Liabilities	167	109	76	51	43	33	35	19	20	21	17	14	10	5
Total Liabilities	1131	606	439	317	228	158	139	85	88	90	40	35	29	20
Fixed Assets	383	251	185	137	103	62	29	14	15	10	8	9	10	8
CWIP	2	7	6	5	5	3	0	0	0	2	0	0	0	0
Investments	264	92	54	44	5	8	33	10	14	16	0	0	0	0
Other Assets	483	256	193	130	116	85	77	61	59	63	32	26	19	12
Total Assets	1131	606	439	317	228	158	139	85	88	90	40	35	29	20

Delivery

Delivery Data: ZOTA

#	Date	1022 45% 1478	Value (Cr)	Q/T 49	Del 54	Del 12
1	4-Sep	1132	10	16	53	5
2	3-Sep	1101	4	12	61	3
3	2-Sep	1078	9	21	50	5
4	1-Sep	1028	6	17	65	4
5	31-Aug	1054	6	14	77	4
6	28-Aug	1083	17	25	68	12
7	27-Aug	1081	4	15	56	2
8	26-Aug	1077	4	16	59	3
9	25-Aug	1077	12	21	64	8
10	24-Aug	1094	9	13	49	4
11	21-Aug	1087	6	15	54	3
12	20-Aug	1077	8	20	69	6
13	19-Aug	1115	22	27	63	14
14	18-Aug	1085	11	20	50	6
15	17-Aug	1111	19	22	59	11
16	14-Aug	1131	46	17	46	21
17	13-Aug	1241	18	90	79	14
18	12-Aug	1250	26	52	90	24
19	11-Aug	1258	3	14	64	2
20	10-Aug	1272	2	9	58	1
21	7-Aug	1275	5	12	35	2
22	6-Aug	1246	2	13	67	1
23	5-Aug	1252	4	14	50	2
24	4-Aug	1252	5	12	52	3
25	3-Aug	1266	5	10	59	3
26	31-Jul	1279	4	14	57	2
27	30-Jul	1225	4	19	64	3
28	29-Jul	1243	3	13	60	2
29	28-Jul	1275	7	26	17	1
30	27-Jul	1283	5	11	50	3
31	24-Jul	1258	6	12	63	4
32	23-Jul	1296	3	9	51	2
33	22-Jul	1277	10	15	64	7
34	21-Jul	1331	3	11	52	1
35	20-Jul	1331	4	10	55	2
36	17-Jul	1350	4	11	56	3
37	16-Jul	1370	3	12	55	2
38	15-Jul	1365	6	15	59	4
39	14-Jul	1386	7	17	77	5
40	13-Jul	1437	12	13	52	6
41	10-Jul	1423	14	17	51	7
42	9-Jul	1418	9	16	56	5
43	8-Jul	1413	11	13	41	5
44	7-Jul	1402	7	25	79	6
45	6-Jul	1421	6	10	56	3
46	3-Jul	1445	8	20	53	4
47	2-Jul	1438	7	19	58	4
48	1-Jul	1431	12	16	46	5
49	30-Jun	1417	15	18	54	8
50	29-Jun	1396	20	20	63	13

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	3,915c	175c	4.68
03-Sep	3,740c	109c	3.00
01-Sep	3,631c	84c	2.27
31-Aug	3,715c	17c	0.46
26-Aug	3,733c	5c	0.13
25-Aug	3,738c	38c	1.00
24-Aug	3,775c	40c	1.07
21-Aug	3,736c	143c	3.70
19-Aug	3,879c	121c	3.23
18-Aug	3,758c	113c	2.91
17-Aug	3,870c	61c	1.54
14-Aug	3,931c	408c	9.40
13-Aug	4,339c	24c	0.55
12-Aug	4,315c	97c	2.20
11-Aug	4,412c	69L	0.02
10-Aug	4,413c	84c	1.94
06-Aug	4,329c	46c	1.04
04-Aug	4,375c	23c	0.53
03-Aug	4,398c	51c	1.17
31-Jul	4,347c	115c	2.71
30-Jul	4,232c	117c	2.70
29-Jul	4,350c	78c	1.75
28-Jul	4,427c	30c	0.67
27-Jul	4,457c	94c	2.14
24-Jul	4,364c	0	0

Stock Checklist

Price is above from 52 week high low average: 15%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 4 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹36 Cr · 4 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
WhiteOak Capital Mutual Fund	4	0.76%	+0.10%	35.9

Zota Health Care LImited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements